3 436

Cited 415 times in

Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon γ Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country

DC Field Value Language
dc.contributor.author강영애-
dc.date.accessioned2015-08-26T16:34:30Z-
dc.date.available2015-08-26T16:34:30Z-
dc.date.issued2005-
dc.identifier.issn0098-7484-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/114728-
dc.description.abstractCONTEXT: A recently developed whole-blood interferon gamma (IFN-gamma) assay based on stimulation with the Mycobacterium tuberculosis-specific antigens early secreted antigenic target 6 and culture filtrate protein 10 shows promise for the diagnosis of latent tuberculosis (TB) infection. OBJECTIVE: To compare the tuberculin skin test (TST) and the whole-blood IFN-gamma assay in the diagnosis of latent TB infection according to the intensity of exposure. DESIGN AND SETTING: A prospective comparison between the whole-blood IFN-gamma assay and the TST using a 2-TU dose of purified protein derivative RT23 in a population with intermediate TB burden was conducted sequentially between February 1, 2004, and February 28, 2005, in a Korean tertiary referral hospital. PARTICIPANTS: Of 273 participants, 220 (95.7%) had received BCG vaccine. Participants were grouped according to their risk of infection: group 1, no identifiable risk of M tuberculosis infection (n = 99); group 2, recent casual contacts (n = 72); group 3, recent close contacts (n = 48); group 4, bacteriologically or pathologically confirmed TB patients (n = 54). MAIN OUTCOME MEASURES: Levels of agreement between the TST and the IFN-gamma assay and the likelihood of infection in the various groups. RESULTS: For the TST with a 10-mm induration cutoff, the positive response rate in group 1 was 51%; group 2, 60%; group 3, 71%, and group 4, 78%. For the IFN-gamma assay, the positive response rate in group 1 was 4%; group 2, 10%; group 3, 44%; and group 4, 81%. The overall agreement between the TST and the IFN-gamma assay in healthy volunteers was kappa = 0.16. The odds of a positive test result per unit increase in exposure across the 4 groups increased by a factor of 5.31 (95% confidence interval [CI], 3.62-7.79) for the IFN-gamma assay and by a factor of 1.52 (95% CI, 1.20-1.91) for the TST (P<.001). Using a 15-mm induration cutoff for the TST did not make a substantial difference to the test results. CONCLUSION: The IFN-gamma assay is a better indicator of the risk of M tuberculosis infection than TST in a BCG-vaccinated population.-
dc.description.statementOfResponsibilityopen-
dc.format.extent2756~2761-
dc.relation.isPartOfJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdolescent-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAntigens, Bacterial/immunology-
dc.subject.MESHBCG Vaccine-
dc.subject.MESHBacterial Proteins/immunology-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHInterferon-gamma/immunology*-
dc.subject.MESHKorea-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMycobacterium tuberculosis/immunology-
dc.subject.MESHMycobacterium tuberculosis/isolation & purification*-
dc.subject.MESHMycobacterium tuberculosis/physiology-
dc.subject.MESHRisk-
dc.subject.MESHTuberculin Test*-
dc.subject.MESHTuberculosis, Pulmonary/diagnosis*-
dc.subject.MESHTuberculosis, Pulmonary/immunology-
dc.subject.MESHVirus Latency-
dc.titleDiscrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon γ Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorYoung Ae Kang-
dc.contributor.googleauthorHye Won Lee-
dc.contributor.googleauthorJae-Joon Yim-
dc.contributor.googleauthorYoung-Soo Shim-
dc.contributor.googleauthorSung Koo Han-
dc.contributor.googleauthorBeLong Cho-
dc.contributor.googleauthorHo Il Yoon-
dc.identifier.doi10.1001/jama.293.22.2756-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00057-
dc.relation.journalcodeJ01196-
dc.identifier.eissn1538-3598-
dc.identifier.pmid15941805-
dc.identifier.urlhttp://jama.jamanetwork.com/article.aspx?articleid=201039-
dc.subject.keyword15941805-
dc.contributor.alternativeNameKang, Young Ae-
dc.contributor.affiliatedAuthorKang, Young Ae-
dc.rights.accessRightsnot free-
dc.citation.volume293-
dc.citation.number22-
dc.citation.startPage2756-
dc.citation.endPage2761-
dc.identifier.bibliographicCitationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.293(22) : 2756-2761, 2005-
dc.identifier.rimsid46080-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.